Welcome to our dedicated page for Materialise news (Ticker: MTLS), a resource for investors and traders seeking the latest updates and insights on Materialise stock.
Materialise NV (MTLS) is a global leader in 3D printing solutions and additive manufacturing software, serving healthcare, automotive, and industrial sectors since 1990. This page aggregates official announcements and verified news about the company’s medical innovations, software developments, and manufacturing advancements.
Investors and industry professionals will find timely updates on quarterly earnings, strategic partnerships, and technology breakthroughs. Our curated collection includes regulatory filings, product launch details, and market expansion news – all essential for understanding Materialise’s position in the evolving digital manufacturing landscape.
Key updates cover developments across Materialise’s three core segments: medical applications improving patient care through 3D-printed implants, software solutions optimizing production workflows, and manufacturing services enabling rapid prototyping. Bookmark this page to monitor how the company addresses challenges in sustainable production and customized healthcare solutions.
Materialise (NASDAQ:MTLS), a leading additive manufacturing software and 3D printing solutions provider, has announced its upcoming Annual General Shareholders' Meeting (AGM) scheduled for June 3, 2025, at 10:00 am CET. The company will also hold an Extraordinary Shareholders' Meeting on the same date to vote on proposed amendments to its articles of association. The key proposals include:
- Renewal of Board of Directors' authorization to increase authorized share capital
- Modification of the statutory AGM date starting in 2026
All relevant documents, including the annual report and meeting notices, are accessible on the company's investor relations website.
Materialise (NASDAQ:MTLS) reported Q1 2025 financial results with total revenue increasing 4.3% to 66,379 kEUR, primarily driven by an 18.7% growth in the Medical segment. The company posted a net loss of (535) kEUR or (0.01) EUR per share, compared to a profit of 3,585 kEUR in Q1 2024.
Key metrics include:
- Medical segment revenue up 18.7% to 31,078 kEUR
- Software segment revenue down 6.4% to 9,775 kEUR
- Manufacturing segment revenue decreased 5.5% to 25,526 kEUR
- Adjusted EBIT declined to 646 kEUR from 2,656 kEUR year-over-year
- Net cash position improved by 6,716 kEUR to 67,736 kEUR
The company maintained its FY2025 guidance, expecting consolidated revenue between 270,000-285,000 kEUR and Adjusted EBIT of 6,000-10,000 kEUR, despite ongoing macro-economic and geo-political uncertainties.
Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing services, has scheduled its first quarter 2025 earnings release for Thursday, April 24, 2025 at 6:30 a.m. ET/12:30 p.m. CET.
The company will host a conference call with senior management to discuss Q1 2025 financial results on the same day at 8:30 a.m. ET/2:30 p.m. CET. Participants can choose to dial in or receive a call to connect to the conference. Additionally, a live audio webcast will be available through the investor relations website and will be archived for future reference.
Materialise (NASDAQ:MTLS) reported its Q4 and full-year 2024 results, showing mixed performance across segments. Total revenue increased 0.6% to 65,680 kEUR in Q4 2024, driven by 14.3% growth in the Medical segment. Full-year 2024 revenue grew 4.2% to 266,765 kEUR.
The company's Medical segment continued strong performance with record-high revenues, while Manufacturing segment faced challenges from European industrial sector headwinds. Q4 Adjusted EBITDA decreased to 4,306 kEUR from 8,474 kEUR in 2023, while net profit improved to 2,907 kEUR (0.05 EUR per share) from a loss of 539 kEUR.
For 2025, Materialise expects consolidated revenues between 270,000-285,000 kEUR and Adjusted EBIT of 6,000-10,000 kEUR. The company maintains strong financials with cash reserves of 102,304 kEUR and reduced gross debt to 41,284 kEUR by end of 2024.
Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and 3D printing services, has scheduled its fourth quarter 2024 earnings release for Thursday, February 20, 2025, at 6:30 a.m. ET/12:30 p.m. CET.
The company will host a conference call with senior management to discuss the financial results at 8:30 a.m. ET/2:30 p.m. CET on the same day. Participants can choose to dial in or receive a call through a registration link. Additionally, a live audio webcast will be available through the investor relations website and will be archived for future reference.
Materialise (NASDAQ:MTLS) reported strong Q3 2024 results with total revenue increasing 14.2% to 68,652 kEUR. The company saw revenue growth across all three business segments, with Medical segment showing exceptional growth of 24.5%. Gross profit margin improved to 57.2% from 56.0% year-over-year. Adjusted EBIT increased 89% to 4,408 kEUR, while net profit decreased to 3,038 kEUR from 4,013 kEUR in Q3 2023. The company maintains its full-year 2024 revenue guidance of 265,000 to 275,000 kEUR and Adjusted EBIT guidance of 11,000 to 14,000 kEUR.
Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing services, has announced the release date for its third quarter 2024 financial results. The company will disclose its earnings on Thursday, October 24, 2024, at 6:30 a.m. ET/12:30 p.m. CET.
Following the release, Materialise's senior management will host a conference call at 8:30 a.m. ET/2:30 p.m. CET to discuss the financial results. Interested participants can access the call via phone by registering through a provided link. Additionally, a live audio webcast will be available through the company's investor relations website. The webcast recording will be archived on Materialise's website for future reference.
Materialise NV (NASDAQ:MTLS) reported strong Q2 2024 results with record-high quarterly revenue of 68,797 kEUR, a 6.2% increase year-over-year. Key highlights include:
- Gross profit margin of 57.0%, in line with 57.2% in Q2 2023
- Adjusted EBIT increased to 3,872 kEUR from (597) kEUR in Q2 2023
- Net profit of 3,875 kEUR, or 0.07 EUR per diluted share
- All three business segments reported increased revenue
- Materialise Medical grew by 13%
- Acquisition of FEops in July 2024 to advance personalized heart disease treatment
The company maintains its full-year 2024 guidance of 265,000 to 275,000 kEUR in revenue and Adjusted EBIT of 11,000 to 14,000 kEUR.
Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing services, has announced its plans to release financial results for the second quarter ended June 30, 2024 on Wednesday, July 31, 2024 at 6:30 a.m. ET/12:30 p.m. CET. The company will hold a conference call to discuss these results on the same day at 8:30 a.m. ET/2:30 p.m. CET. Interested parties can access the call via phone by registering through a provided link or listen to a live audio webcast through the company's investor relations website. The webcast will be archived for future reference.
Materialise (NASDAQ: MTLS), a leader in additive manufacturing software and 3D printing solutions, has scheduled its Annual General Shareholders' Meeting for June 4, 2024, at 10:00 am CEST. The meeting will be held in Leuven, Belgium.
All relevant documents, including the annual report, are available on Materialise's investor website.
FAQ
What is the current stock price of Materialise (MTLS)?
What is the market cap of Materialise (MTLS)?
